5001842026-07-012026-09-305001842026-09-305001842026-03-315001842026-04-012026-09-305001842026-07-012026-09-30in-capmkt:OtherExpenses1Member5001842026-04-012026-09-30in-capmkt:OtherExpenses1Member5001842026-09-30OtherNoncurrentFinancialAssetsDomain15001842026-09-30OtherNoncurrentAssetsDomain15001842026-09-30OtherCurrentFinancialAssetsDomain15001842026-09-30OtherCurrentAssetsDomain15001842026-09-30OtherNoncurrentFinancialLiabilitiesDomain15001842026-09-30OtherCurrentFinancialLiabilitiesDomain15001842026-09-30OtherCurrentLiabilitiesDomain15001842026-07-012026-09-30in-capmkt:ReportableSegments1Member5001842026-07-012026-09-30in-capmkt:ReportableSegments2Member5001842026-07-012026-09-30in-capmkt:ReportableSegments3Member5001842026-04-012026-09-30in-capmkt:ReportableSegments1Member5001842026-04-012026-09-30in-capmkt:ReportableSegments2Member5001842026-04-012026-09-30in-capmkt:ReportableSegments3Member5001842026-07-012026-09-30in-capmkt:ReportableSegments1Member5001842026-07-012026-09-30in-capmkt:ReportableSegments2Member5001842026-07-012026-09-30in-capmkt:ReportableSegments3Member5001842026-04-012026-09-30in-capmkt:ReportableSegments1Member5001842026-04-012026-09-30in-capmkt:ReportableSegments2Member5001842026-04-012026-09-30in-capmkt:ReportableSegments3Member5001842026-07-012026-09-30in-capmkt:ReportableSegments1Member5001842026-09-30in-capmkt:ReportableSegments1Member5001842026-07-012026-09-30in-capmkt:ReportableSegments2Member5001842026-09-30in-capmkt:ReportableSegments2Member5001842026-07-012026-09-30in-capmkt:ReportableSegments3Member5001842026-09-30in-capmkt:ReportableSegments3Member5001842026-07-012026-09-30in-capmkt:ReportableSegments1Member5001842026-09-30in-capmkt:ReportableSegments1Member5001842026-07-012026-09-30in-capmkt:ReportableSegments2Member5001842026-09-30in-capmkt:ReportableSegments2Member5001842026-07-012026-09-30in-capmkt:ReportableSegments3Member5001842026-09-30in-capmkt:ReportableSegments3Member5001842026-07-012026-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842026-07-012026-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842026-04-012026-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842026-04-012026-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842026-07-012026-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15001842026-04-012026-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500184HSCLNOTLISTEDINE019C01026Himadri Speciality Chemical LimitedMain BoardEquity2026-04-012027-03-312026-10-162026-10-09INRCroresQuarterlySecond quarterMulti segment2026-10-1617:00:002026-10-1617:50:00trueCash Flow IndirectNot applicable2026-07-012026-09-30UnauditedConsolidated1691430000041790000017332200000114392000001524300000-1253400000606800000277200000216900000144780000014258800000307340000003073400000696100000641000007602000000231320000000002313200000880000023220000002323200000-100000002332800000-1080000050460000014.64.6004.64.60.00220.08930.1287 <br /> (3) The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 16 October 2026. A Limited Review of these consolidated financial results for the quarter and six months ended 30 September 2026 has been carried out by the Statutory Auditors, as required under Regulation 33 and Regulation 52 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <br /> <br /> <br /> (4) Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs (11.74) crores for the quarter ended 30 September 2026, Rs 25.20 crores for the quarter ended 30 June 2026, Rs 5.07 crores for the quarter ended 30 September 2025, Rs 13.46 crores for the six months ended 30 September 2026, Rs (4.69) crores for the six months ended 30 September 2025 and Rs 43.56 crores for the year ended 31 March 2026. <br /> <br /> (5) Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within following operating segments, namely: <br /> (a) Carbon materials and chemicals, and <br /> (b) Power <br /> (c) Others (includes Mining and Other business) <br /> <br /> (6) (a) The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. <br /> The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited, Himadri Speciality Inc, Himadri Agro Tech Specialities Limited (formerly Combe Projects Private Ltd. and Combe Projects Ltd.), Himadri Clean Energy Limited, Himadri Future Material Technology Limited, Invati Creations Private Limited, Himadri Green Technologies Innovation Limited, Birla Tyres Limited (w.e.f 01 April 2025), Himadri Birla Tyre Manufacturer Private Limited (w.e.f 01 April 2025), Trancemarine and Confreight Logistics Private Limited (w.e.f 04 April 2025), Sturdy Niketan Private Limited (w.e.f 04 April 2025), Himadri Advance New Energy Material Limited (formerly, Elixir Carbo Private Ltd. and Elixir Carbo Ltd.) (w.e.f 22 April 2025), Himadri Integrated Minerals And Resources Limited (formerly, Himadri Power Ltd.) (w.e.f 11 February 2026) and Ardent Impex Fzco (w.e.f 22 June 2026) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). <br /> <br /> The consolidated financial results are prepared applying uniform accounting policies on all material items. <br /> <br /> (7) The Nomination and Remuneration Committee of the Holding Company at its meeting held on 10 August 2026, has allotted 13,576 equity shares of Re 1 each (Under Grant II) to the option grantees pursuant to exercise of options under the Holding Company’s “Himadri Employee Stock Option Plan 2016”. As a result of such allotment, the paid up equity share capital of the Holding Company has increased from 50,45,60,599 equity shares to 50,45,74,175 equity shares of face value of Re 1 each. <br /> <br /> (8) The Board of Holding Company at its meeting held on 21 September 2026, subject to receipt of requisite approvals from statutory and regulatory authorities, considered and approved the Scheme of Arrangement between Dalmia Bharat Refractories Limited (“DBRL” or “Demerged Company”) and the Holding Company (“HSCL” or “Resulting Company”) and their respective shareholders and creditors pursuant to Section 230 to 232 read with other applicable provisions of the Companies Act, 2013 and the rules framed thereunder (“Scheme”). <br /> <br /> The Scheme, inter-alia, provides for demerger by way of transfer and vesting of the Tyre Business of DBRL (“Demerged Undertaking”) from DBRL to HSCL as a going concern w.e.f the proposed appointed date i.e. 1 October 2026, on an as is where is basis, and the consequent issuance of Resulting Company New Shares (as defined in the Scheme) by HSCL to the eligible shareholders of DBRL in accordance with the Share Entitlement Ratio (as defined in the Scheme) in the manner set forth in the Scheme. <br /> <br /> The scheme has since been filed with stock exchanges for approval. <br /> <br /> (9) Earnings per share is not annualised for the quarter ended 30 September 2026, 30 June 2026, 30 September 2025, six months ended 30 September 2026 and 30 September 2025. <br /> <br /> 2026-04-012026-09-30UnauditedConsolidated3123310000098100000032214100000214726000002670700000-331210000011895000005013000004299000003183700000261356000006078500000060785000001313400000167600000148100000004597500000000045975000006460000046621000004618400000-209000004684400000-2230000050460000019.159.15009.159.150.00220.09010.1398Other Expenses1447800000Other Expenses3183700000189283000003700600000024430000098750000012262300000101800000016870000001405110000016160000014024000003947580000080568000002342000001026180000095930000051672000001421000003174000001708200000005153600000302924000000069768200000504600000508476000005135220000053170000051883900000358000000002560000061400000155200000305170000032683000001152260000037600000156710000016047000005082000001363550000016080000039300000780400000146160000001788430000069768200000Other non-current financial assets1687000000Other non-current assets1402400000Other financial assets317400000Other current assets5153600000Other non-current financial liabilities25600000Other current financial liabilities508200000Other current liabilities160800000Carbon materials and chemicals15390200000Power333200000Others1441400000Carbon materials and chemicals28179200000Power652000000Others288030000017164800000317115000002505000004784000001691430000031233100000Carbon materials and chemicals2516400000Power298400000Others500000Carbon materials and chemicals5142000000Power579400000Others1200000028153000005733400000277200000501300000-535300000-84640000030734000006078500000Carbon materials and chemicals44281700000Power1008500000Others3627200000489174000002085080000069768200000Carbon materials and chemicals1286900000Power6600000Others115810000024516000001543270000017884300000Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocable501300000-427200000-31699000000-69360000019000000-9362000000-21503000000576000000429900000000-2365000000-12680000002496000000000049000000-6994500000-9160000000006275000000-154350000000000000168000001730400000011152000000800000000000000000001530000000526800000-2149800000000000460000007600000-388520000010800000403600000478000000003005000000-6883000000-6883000001647600000959300000Remeasurements of the net defined benefit plan-500000Net gain/ (loss) on investment in equity instruments accounted at fair value900000400000Remeasurements of the net defined benefit plan-1000000Net gain/ (loss) on investment in equity instruments accounted at fair value384000003740000005200000Exchange differences in translating financial statements of foreign operations84000008400000Exchange differences in translating financial statements of foreign operations324000003240000000880000064600000